These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 39000373)

  • 1. Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV.
    Hmiel L; Zhang S; Obare LM; Santana MAO; Wanjalla CN; Titanji BK; Hileman CO; Bagchi S
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
    Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
    Front Immunol; 2019; 10():1378. PubMed ID: 31275317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease.
    Obare LM; Temu T; Mallal SA; Wanjalla CN
    Circ Res; 2024 May; 134(11):1515-1545. PubMed ID: 38781301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.
    Kaplan-Lewis E; Aberg JA; Lee M
    Curr HIV/AIDS Rep; 2016 Oct; 13(5):297-308. PubMed ID: 27562769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease and Thrombosis in HIV Infection.
    Perkins MV; Joseph SB; Dittmer DP; Mackman N
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):175-191. PubMed ID: 36453273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trained immunity and atherosclerotic cardiovascular disease.
    Riksen NP
    Curr Opin Lipidol; 2019 Oct; 30(5):395-400. PubMed ID: 31335332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis.
    El-Far M; Durand M; Turcotte I; Larouche-Anctil E; Sylla M; Zaidan S; Chartrand-Lefebvre C; Bunet R; Ramani H; Sadouni M; Boldeanu I; Chamberland A; Lesage S; Baril JG; Trottier B; Thomas R; Gonzalez E; Filali-Mouhim A; Goulet JP; Martinson JA; Kassaye S; Karim R; Kizer JR; French AL; Gange SJ; Ancuta P; Routy JP; Hanna DB; Kaplan RC; Chomont N; Landay AL; Tremblay CL
    Front Immunol; 2021; 12():664371. PubMed ID: 33936102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trained Immunity in Atherosclerotic Cardiovascular Disease.
    Flores-Gomez D; Bekkering S; Netea MG; Riksen NP
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):62-69. PubMed ID: 33147995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and atherosclerosis: evaluating the drivers of inflammation.
    Maniar A; Ellis C; Asmuth D; Pollard R; Rutledge J
    Eur J Prev Cardiol; 2013 Oct; 20(5):720-8. PubMed ID: 22556374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T cells in the development of cardiovascular disease in HIV-infected patients.
    Krikke M; van Lelyveld SF; Tesselaar K; Arends JE; Hoepelman IM; Visseren FL
    Atherosclerosis; 2014 Nov; 237(1):92-8. PubMed ID: 25238214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in atherosclerosis: transition from theory to practice.
    Libby P; Okamoto Y; Rocha VZ; Folco E
    Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases.
    Butterfield TR; Landay AL; Anzinger JJ
    Curr HIV/AIDS Rep; 2020 Apr; 17(2):125-137. PubMed ID: 32140979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-related mechanisms in atherosclerosis and cardiovascular diseases.
    Gibellini D; Borderi M; Clò A; Morini S; Miserocchi A; Bon I; Ponti C; Re MC
    J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):780-90. PubMed ID: 23656915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte/Macrophage-Mediated Innate Immunity in HIV-1 Infection: From Early Response to Late Dysregulation and Links to Cardiovascular Diseases Onset.
    Teer E; Joseph DE; Glashoff RH; Faadiel Essop M
    Virol Sin; 2021 Aug; 36(4):565-576. PubMed ID: 33400091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Eosinophils as a Feature of Inflammation Associated With Hypertension in Virally Suppressed People Living With HIV.
    Masenga SK; Elijovich F; Hamooya BM; Nzala S; Kwenda G; Heimburger DC; Mutale W; Munsaka SM; Zhao S; Koethe JR; Kirabo A
    J Am Heart Assoc; 2020 Feb; 9(4):e011450. PubMed ID: 32064996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.
    Hearps AC; Martin GE; Rajasuriar R; Crowe SM
    Curr HIV/AIDS Rep; 2014 Mar; 11(1):20-34. PubMed ID: 24414166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and aging of the innate immune system.
    Hearps AC; Angelovich TA; Jaworowski A; Mills J; Landay AL; Crowe SM
    Sex Health; 2011 Dec; 8(4):453-64. PubMed ID: 22127030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells and atherosclerosis: A HIV perspective.
    Obare LM; Bonami RH; Doran AC; Wanjalla CN
    J Cell Physiol; 2024 Jun; 239(6):e31270. PubMed ID: 38651687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.